Mutations in latent membrane protein 1 of Epstein-Barr virus are associated with increased risk of posttransplant lymphoproliferative disorder in children
Open Access
- 15 February 2023
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (5) , 611-618
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (UM2AI117870)
- National Institute of Allergy and Infectious Diseases (5U01AI104342)
This publication has 31 references indexed in Scilit:
- Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative DisorderAmerican Journal of Transplantation, 2013
- The novel anti-MEK small molecule AZD6244 induces BIM-dependent and AKT-independent apoptosis in diffuse large B-cell lymphomaBlood, 2011
- Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphomaNature Communications, 2011
- Chronic high Epstein-Barr viral load carriage in pediatric small bowel transplant recipientsPediatric Transplantation, 2010
- Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell LymphomaCancer Research, 2009
- Chronic high Epstein‐Barr viral load carriage in pediatric liver transplant recipientsPediatric Transplantation, 2009
- Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-FosJournal of Biological Chemistry, 2008
- Confidence intervals for predictive values with an emphasis to case–control studiesStatistics in Medicine, 2007
- Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantationCritical Reviews in Oncology/Hematology, 2005
- Post-Transplant Lymphoproliferative Disorder in ChildrenPediatric Drugs, 2005